Exelixis, Inc.
EXEL
$37.02
$0.371.01%
| Weiss Ratings | EXEL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Excellent | |||
| Risk Index | Fair | |||
| Risk Grade | C+ | |||
| Reward Grade | A- | |||
| Rating Factors | EXEL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Excellent | |||
| Efficiency Index | Good | |||
| Solvency Index | Excellent | |||
| Total Return Index | Good | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | EXEL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.14 | |||
| Price History | EXEL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -3.11% | |||
| 30-Day Total Return | 11.67% | |||
| 60-Day Total Return | 2.63% | |||
| 90-Day Total Return | 8.50% | |||
| Year to Date Total Return | 9.07% | |||
| 1-Year Total Return | 61.10% | |||
| 2-Year Total Return | 107.98% | |||
| 3-Year Total Return | 82.36% | |||
| 5-Year Total Return | 156.02% | |||
| 52-Week High % Change | -8.42% | |||
| 52-Week Low % Change | 81.98% | |||
| Price | EXEL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $40.02 | |||
| 52-Week Low Price | $20.14 | |||
| 52-Week Low Price (Date) | May 29, 2024 | |||
| 52-Week High Price (Date) | Mar 10, 2025 | |||
| Valuation | EXEL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 10.26B | |||
| Enterprise Value | 9.36B | |||
| Price/Earnings (TTM) | 20.70 | |||
| Earnings Per Share (TTM) | 1.77 | |||
| Earnings Per Share Growth | 173.56% | |||
| Price/Earnings To Growth | 0.12 | |||
| Price/Sales (TTM) | 4.96 | |||
| Price/Book (Q) | 4.60 | |||
| Enterprise Value/Revenue (TTM) | 4.32 | |||
| Price | $37.02 | |||
| Enterprise Value/EBITDA (TTM) | 13.03 | |||
| Enterprise Value/EBIT | 13.57 | |||
| Market Cap Category | Large Cap | |||
| Dividends and Shares | EXEL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 293.55M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | EXEL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 650 837 7000 | |||
| Address | 1851 Harbor Bay Parkway Alameda, CA 94502 | |||
| Website | www.exelixis.com | |||
| Country | United States | |||
| Year Founded | 1994 | |||
| Profitability | EXEL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 31.81% | |||
| Profit Margin | 24.03% | |||
| Management Effectiveness | EXEL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 14.64% | |||
| Return on Equity | 23.13% | |||
| Income Statement | EXEL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 2.17B | |||
| Total Revenue (TTM) | 2.17B | |||
| Revenue Per Share | $7.39 | |||
| Gross Profit (TTM) | 2.09B | |||
| EBITDA (TTM) | 718.75M | |||
| EBIT (TTM) | 689.95M | |||
| Net Income (TTM) | 521.27M | |||
| Net Income Avl. to Common (TTM) | 521.27M | |||
| Total Revenue Growth (Q YOY) | 18.16% | |||
| Earnings Growth (Q YOY) | 63.55% | |||
| EPS Diluted (TTM) | 1.77 | |||
| EPS Diluted Growth (Q YOY) | 75.43% | |||
| Balance Sheet | EXEL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.11B | |||
| Cash Per Share (Q) | $3.79 | |||
| Total Current Assets (Q) | 1.47B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 2.24B | |||
| Current Ratio (Q) | 3.635 | |||
| Book Value Per Share (Q) | $7.97 | |||
| Total Assets (Q) | 2.95B | |||
| Total Current Liabilities (Q) | 403.77M | |||
| Total Debt (Q) | 215.83M | |||
| Total Liabilities (Q) | 703.49M | |||
| Total Common Equity (Q) | 2.24B | |||
| Cash Flow | EXEL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -116.78M | |||
| Cash from Financing (TTM) | -628.81M | |||
| Net Change in Cash (TTM) | -45.62M | |||
| Levered Free Cash Flow (TTM) | 464.22M | |||
| Cash from Operations (TTM) | 699.97M | |||
